| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $24.0M | +18.4% |
| SG&A Expense | $13.9M | +10.2% |
| Operating Income | -$37.9M | +9.7% |
| Pre-tax Income | -$37.3M | +9.6% |
| Income Tax | $0 | — |
| Net Income | -$37.3M | +9.6% |
| EPS (Basic) | -$1.34 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.5M | -85.2% |
| Current Assets | $3.2M | -82.1% |
| Total Assets | $6.2M | -70.3% |
| Current Liabilities | $13.7M | -11.5% |
| Total Liabilities | $14.2M | -11.8% |
| Stockholders' Equity | -$8.0M | -264.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.4M | -31.9% |
| Investing Cash Flow | -$5.5M | -22.2% |
| Financing Cash Flow | $22.3M | -7.3% |
| +37.1% |
| EPS (Diluted) | -$1.34 | +37.1% |